Jonathan M Peacock Insider Trading $BLPH Bellerophon Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jonathan M Peacock.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jonathan M Peacock. Jonathan M Peacock is CFO in AMGEN INC ($AMGN) and EVP & CFO in AMGEN INC ($AMGN) and Director in Kite Pharma, Inc. ($KITE) and in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Bellerophon Therapeutics, Inc. ($BLPH) and President and CEO in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Avantor, Inc. ($AVTR).
Jonathan M Peacock in Bellerophon Therapeutics, Inc.
Trading Symbol: BLPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jonathan M Peacock:
Holdings: 157,033 shares
Current Value: $103,642
Latest Transaction: Apr 02 2021
$BLPH Market Capitalization: $9.84M
$BLPH Previous Close: $0.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jonathan M Peacock in Bellerophon Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMGN, AVTR, BLPH, KITE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2021 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Grant | A | 0.00 | 15,308 | 0 | 157,033 | 141.7 K to 157 K (+10.80 %) | |
Jan 27 2020 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Grant | A | 0.00 | 350,000 | 0 | 2,225,920 | 1.9 M to 2.2 M (+18.66 %) |
Jan 27 2020 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Grant | A | 0.00 | 350,000 | 0 | 2,225,920 | 1.9 M to 2.2 M (+18.66 %) |
May 22 2019 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Buy | P | 0.61 | 20,000 | 12,198 | 1,875,920 | 1.9 M to 1.9 M (+1.08 %) |
Jan 25 2019 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Buy | P | 0.70 | 714,286 | 500,000 | 1,855,920 | 1.1 M to 1.9 M (+62.57 %) |
Jan 25 2019 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Grant | A | 0.00 | 227,273 | 0 | 1,141,634 | 914.4 K to 1.1 M (+24.86 %) |
Apr 03 2018 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Grant | A | 0.00 | 99,010 | 0 | 914,361 | 815.4 K to 914.4 K (+12.14 %) |
Oct 03 2017 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Option Exercise | P | 1.24 | 248,962 | 309,211 | 248,962 | |
Oct 03 2017 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Buy | P | 0.00 | 248,962 | 0 | 815,351 | 566.4 K to 815.4 K (+43.96 %) |
Sep 26 2017 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Option Exercise | A | 1.12 | 10,000 | 11,200 | 10,000 | |
Jun 30 2017 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Grant | A | 0.00 | 57,972 | 0 | 566,389 | 508.4 K to 566.4 K (+11.40 %) |
Dec 09 2016 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Option Exercise | A | 0.49 | 588,373 | 288,303 | 588,373 | |
Nov 30 2016 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Option Exercise | P | 0.80 | 285,715 | 228,572 | 285,715 | |
Nov 30 2016 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | Director | Buy | P | 0.00 | 285,715 | 0 | 508,417 | 222.7 K to 508.4 K (+128.29 %) |
May 18 2016 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 1.37 | 5,000 | 6,842 | 222,702 | 217.7 K to 222.7 K (+2.30 %) |
Jan 27 2016 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Grant | A | 0.00 | 165,975 | 0 | 217,702 | 51.7 K to 217.7 K (+320.87 %) |
Dec 17 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 2.76 | 12,800 | 35,336 | 51,727 | 38.9 K to 51.7 K (+32.88 %) |
Dec 17 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 2.72 | 7,500 | 20,400 | 38,927 | 31.4 K to 38.9 K (+23.86 %) |
Aug 20 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 5.48 | 5,000 | 27,377 | 31,427 | 26.4 K to 31.4 K (+18.92 %) |
May 22 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 8.69 | 5,560 | 48,323 | 26,427 | 20.9 K to 26.4 K (+26.64 %) |
Mar 16 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Option Exercise | A | 10.22 | 60,000 | 613,200 | 60,000 | |
Mar 16 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Option Exercise | A | 10.22 | 16,000 | 163,520 | 16,000 | |
Feb 23 2015 | BLPH | Bellerophon Therap ... | Peacock Jonathan M | President and CEO | Buy | P | 12.00 | 20,800 | 249,600 | 20,867 | 67 to 20.9 K (+31,044.78 %) |
Page: 1